Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 08 04:00PM ET
3.20
Dollar change
-0.07
Percentage change
-2.14
%
Index- P/E- EPS (ttm)-0.45 Insider Own38.04% Shs Outstand99.20M Perf Week6.67%
Market Cap312.15M Forward P/E- EPS next Y-0.25 Insider Trans0.00% Shs Float61.76M Perf Month-4.19%
Income-44.59M PEG- EPS next Q-0.21 Inst Own28.67% Short Float1.29% Perf Quarter-5.60%
Sales46.86M P/S6.66 EPS this Y5.94% Inst Trans-8.88% Short Ratio8.93 Perf Half Y38.53%
Book/sh1.74 P/B1.84 EPS next Y63.72% ROA-20.00% Short Interest0.80M Perf Year6.67%
Cash/sh1.92 P/C1.67 EPS next 5Y- ROE-30.57% 52W Range2.25 - 5.14 Perf YTD-36.00%
Dividend Est.- P/FCF6.20 EPS past 5Y3.28% ROI-28.38% 52W High-37.74% Beta1.24
Dividend TTM- Quick Ratio1.86 Sales past 5Y305.31% Gross Margin- 52W Low42.22% ATR (14)0.18
Dividend Ex-Date- Current Ratio1.86 EPS Y/Y TTM48.73% Oper. Margin-90.22% RSI (14)51.41 Volatility6.60% 5.29%
Employees161 Debt/Eq0.02 Sales Y/Y TTM4516931.76% Profit Margin-95.16% Recom1.00 Target Price10.22
Option/ShortYes / Yes LT Debt/Eq0.02 EPS Q/Q131.14% Payout- Rel Volume0.83 Prev Close3.27
Sales Surprise251.73% EPS Surprise136.72% Sales Q/Q- EarningsNov 05 BMO Avg Volume89.20K Price3.20
SMA203.64% SMA50-2.13% SMA200-4.36% Trades Volume74,226 Change-2.14%
Date Action Analyst Rating Change Price Target Change
May-31-24Initiated BTIG Research Buy $8
Feb-01-19Downgrade UBS Buy → Neutral
Jan-04-19Initiated UBS Buy
Apr-05-18Initiated H.C. Wainwright Buy $18
Mar-23-18Downgrade Credit Suisse Outperform → Neutral
Oct-18-16Initiated Leerink Partners Outperform
Oct-18-16Initiated Jefferies Buy $25
Oct-18-16Initiated Credit Suisse Outperform $18
Nov-05-24 07:30AM
07:00AM
Oct-23-24 09:12AM
Sep-17-24 07:00AM
Aug-29-24 07:13AM
09:00AM Loading…
Aug-28-24 09:00AM
Aug-06-24 09:25AM
08:23AM
07:00AM
Jul-31-24 08:30AM
Jul-25-24 12:53PM
07:00AM
Jul-16-24 07:00AM
May-28-24 07:00AM
May-13-24 03:58PM
03:37PM Loading…
03:37PM
02:53PM
02:41PM
11:22AM
08:13AM
08:02AM
08:00AM
07:26AM
07:23AM
06:12AM
06:05AM
06:00AM
05:52AM
Mar-14-24 10:52PM
07:00AM
07:00AM Loading…
Feb-22-24 07:00AM
Feb-21-24 11:16AM
Jan-30-24 09:35AM
Jan-22-24 08:48AM
07:00AM
Jan-18-24 12:00PM
Jan-03-24 12:00PM
08:10AM
Dec-15-23 07:56AM
07:22AM
Dec-05-23 05:59AM
Dec-01-23 07:00AM
Nov-28-23 07:33PM
Nov-20-23 06:00AM
Nov-07-23 07:00AM
Nov-03-23 08:37AM
07:00AM
Nov-02-23 07:00AM
Oct-27-23 07:00AM
Oct-24-23 09:40AM
Oct-23-23 10:00AM
Oct-20-23 10:00AM
Oct-18-23 08:26AM
Oct-17-23 07:00AM
Oct-05-23 07:00AM
Sep-05-23 01:09PM
08:48AM
07:00AM
Aug-04-23 08:15AM
07:14AM
07:00AM
Jul-28-23 07:00AM
Jul-26-23 07:00AM
Jul-03-23 07:00AM
Jun-30-23 03:13PM
Jun-27-23 07:00AM
Jun-23-23 04:30PM
Jun-16-23 10:45AM
May-04-23 09:02AM
Apr-28-23 07:14AM
07:00AM
Apr-26-23 08:01PM
Apr-07-23 08:29AM
Apr-05-23 07:00AM
Mar-20-23 08:00AM
Mar-16-23 07:00AM
Mar-08-23 07:00AM
Feb-07-23 07:00AM
Feb-02-23 08:15AM
Jan-27-23 09:57AM
Jan-26-23 07:00AM
Jan-18-23 07:00AM
Jan-07-23 08:45AM
Nov-30-22 07:00AM
Nov-25-22 07:17AM
Nov-23-22 07:30AM
Nov-08-22 07:58AM
Oct-29-22 08:06AM
Oct-28-22 09:25AM
08:00AM
Oct-04-22 08:36AM
Sep-26-22 07:30AM
Sep-01-22 08:00AM
Aug-24-22 04:05PM
Aug-11-22 07:30AM
Aug-02-22 11:00AM
Jul-31-22 08:12AM
Jul-28-22 08:45AM
07:30AM
Jul-22-22 07:30AM
AC Immune SA is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company was founded by Jean-Marie Lehn, Claude Nicolau, Roscoe Brady, Fred van Leuven, Ruth Greferath, Andrea Pfeifer, and Alexey V. Eleesiv on February 13, 2003 and is headquartered in Lausanne, Switzerland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ANDREA M. A PFEIFEROfficerSep 27 '24Proposed Sale3.7040,000148,000Sep 27 04:26 PM
ANDREA M. A PFEIFEROfficerSep 18 '24Proposed Sale3.4620,00069,200Sep 18 04:40 PM